Latest release of Cresset molecular modeling platform delivers improved efficiencies

Cresset, an innovator in Computer-Aided Drug Design (CADD), DMTA efficiency, and contract research, unveils Flare™ V7, the latest iteration of its cutting-edge drug design platform. Flare V7 represents a significant leap forward in molecular modeling by seamlessly integrating the potency of ligand and structure-based techniques to foster more efficient small molecule discovery.

Flare V7 introduces an array of new features and methods aimed at elevating the drug discovery process. Notable enhancements include a substantial upgrade in Dynamics and Flare FEP calculations, the debut of an innovative ensemble docking method, reinforcement of Quantitative Structure-Activity Relationship (QSAR) and Quantum Mechanics (QM) methodologies, and a host of tools to facilitate troubleshooting of Flare FEP experiments, scrutiny of dynamics trajectories, and preparation of ligand structures for comprehensive studies.

Giovanna Tedesco, Head of Products at Cresset, emphasized that the evolution of Flare V7 stems from the latest scientific insights and customer feedback, ensuring that the platform aligns precisely with users' requirements to expedite their drug discovery projects. The incorporation of these cutting-edge methods not only enhances operational efficiencies but also fosters collaborative research within an intuitive and user-friendly environment.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>